Patents by Inventor Paul S. Anderson

Paul S. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5113755
    Abstract: A particulate proteinaceous product and methods for producing the same from waste raw animal parts are disclosed. The product is dry to the touch, is compressible into pellets or cakes, and comprises about 45 to 65 w/w percent partially hydrolyzed, non-denatured animal protein, about 20-35 w/w percent oil derived from the animal parts, about 10-15 w/w percent moisture, and about 0-7 w/w percent ash. The product also has less objectionable odor, less propensity to oxidize, and higher nutritional value than existing products.
    Type: Grant
    Filed: October 1, 1991
    Date of Patent: May 19, 1992
    Assignee: Advanced Hydrolyzing Systems, Inc.
    Inventors: Paul S. Anderson, Roger W. Law, Ronald R. Law, Kenneth Lum
  • Patent number: 5095003
    Abstract: Cyclic peptides are produced by the controlled aerobic fermentation of Streptomyces silvensis, ATTCC No. 53525 or ATCC No. 53526. These compounds are antagonists of oxytocin and are useful in the treatment of preterm labor and vasopressin and are thus useful in the treatment and prevention of disease states wherein vasopressin may be involved, for example congestive heart failure, hypertension, edema and hyponatremia.
    Type: Grant
    Filed: October 23, 1990
    Date of Patent: March 10, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Michael A. Goetz, Lawrence R. Koupal, Cheryl D. Schwartz, Jerrold M. Liesch, Otto D. Hensens, Paul S. Anderson, Roger Freidinger, Douglas J. Pettibone
  • Patent number: 5053234
    Abstract: A particulate proteinaceous product is prepared from waste raw protein-containing animal parts with a method and an apparatus having a mulling stage wherein the raw animal parts are reduced to a ground condition; a hydrolyzing stage wherein proteins in the ground animal parts are hydrolyzed to a predetermined extent to form an aqueous suspension, using either endogenous or supplementary proteolytic enzymes, and subsequently heated to inactivate the enzymes and convert fats in the suspension to oils; a screening stage wherein non-digestible solids are removed from the suspension; a concentration stage wherein extraneous oil is added to the suspension, the suspension is pasteurized, and a large portion of the water is removed therefrom; and an oil-separation stage wherein sufficient oil is removed to form the product.
    Type: Grant
    Filed: June 8, 1990
    Date of Patent: October 1, 1991
    Assignee: Advanced Hydrolyzing Systems, Inc.
    Inventors: Paul S. Anderson, Roger W. Law, Ronald R. Law, Kenneth Lum
  • Patent number: 4589235
    Abstract: A panel partition arrangement for domestic garages, for forming an alternately usable family sports center in the form of a recreation chamber within the space defined by domestic or family home garages and the like that are usually equipped with the familiar overhead type sectionalized garage door, in which the partition arrangement is mounted inside the garage to form with the door in its lowered position a recreation chamber within the garage for accommodating family oriented recreations such as playing ball type game sports and the like, with the garage door sections being faced on their inner sides to be in flush relation in the closed position thereof, and vertical walls being provided to form the side walls and inner end wall of the recreation chamber, of which the indicated vertical walls are flush surfaced, and the floor is obstruction free, for defining the recreation chamber, with the indicated vertical walls optionally being formed to define closet or other storage space that is normally closed at
    Type: Grant
    Filed: March 12, 1984
    Date of Patent: May 20, 1986
    Inventor: Paul S. Anderson
  • Patent number: 4414154
    Abstract: Dibenzo[a,d]cycloocten-5,12-(and 6,12)-imines, derivatives and pharmaceutically acceptable salts thereof are useful as anxiolytics, antidepressants, anticonvulsants, muscle relaxants and in the treatment of mixed anxiety-depression, minimal brain dysfunction and extrapyramidal disorders such as Parkinson's disease.
    Type: Grant
    Filed: October 22, 1981
    Date of Patent: November 8, 1983
    Assignee: Merck & Co. Inc.
    Inventors: Paul S. Anderson, Marcia E. Christy, Ben E. Evans, David C. Remy
  • Patent number: 4374838
    Abstract: Dibenzo[a,d]cycloocten-5,12-(and 6,12)-imines, derivatives and pharmaceutically acceptable salts thereof are useful as anxiolytics, antidepressants, anticonvulsants, muscle relaxants and in the treatment of mixed anxiety-depression, minimal brain dysfunction and extrapyramidal disorders such as Parkinson's disease.
    Type: Grant
    Filed: October 22, 1981
    Date of Patent: February 22, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Paul S. Anderson, Marcia E. Christy, Ben E. Evans, David C. Remy
  • Patent number: 4329465
    Abstract: Dibenzo[a,d]cycloocten-5,12-(and 6,12)-imines, derivatives and pharmaceutically acceptable salts thereof are useful as anxiolytics, antidepressants, anticonvulsants, muscle relaxants and in the treatment of mixed anxiety-depression, minimal brain dysfunction and extrapyramidal disorders such as Parkinson's disease.
    Type: Grant
    Filed: October 1, 1979
    Date of Patent: May 11, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Paul S. Anderson, Marcia E. Christy, Ben E. Evans, David C. Remy
  • Patent number: 4252810
    Abstract: 9,10-Dihydro-4H-benzo[4,5]cyclohepta [1,2-b]thiophen-4,9-imines, derivatives and pharmaceutically acceptable salts thereof are useful as antianxiety agents, as muscle relaxants and in the treatment of extrapyramidal disorders such as in Parkinson's disease.
    Type: Grant
    Filed: November 15, 1978
    Date of Patent: February 24, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Paul S. Anderson, Ben E. Evans
  • Patent number: 4076714
    Abstract: 1-Methyl-4-(2-carboxy-thioxanthen-9-ylidene)-piperidine is disclosed to have pharmaceutical utility as an appetite stimulant and an antihistamine with low antiserotonin and anticholinergic activity. Also disclosed are processes for the preparation of such compound; pharmaceutical compositions comprising such compound; and methods of treatment comprising administering such compound and compositions.
    Type: Grant
    Filed: October 29, 1975
    Date of Patent: February 28, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Paul S. Anderson, David C. Remy
  • Patent number: 4064139
    Abstract: Substituted 9,10-dihydroanthracen-9,10-imines are disclosed to be minor tranquilizers, anticonvulsnts, muscle relaxants, and to be useful in the treatment of extrapyramidal disorders such as Parkinson's disease; also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions.
    Type: Grant
    Filed: October 28, 1976
    Date of Patent: December 20, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Paul S. Anderson, Marcia E. Christy, Gerald S. Ponticello
  • Patent number: 4052508
    Abstract: Heterocyclic dihydroanthracen imines are disclosed to be useful as minor tranquilizers, anticonvulsants, muscle relaxants and to be useful in the treatment of extrapyramidal disorders such as Parkinson's disease; also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions.
    Type: Grant
    Filed: April 7, 1975
    Date of Patent: October 4, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Paul S. Anderson, Marcia E. Christy, Gerald S. Ponticello
  • Patent number: 3987183
    Abstract: Disclosed are certain polycyclic imidazoles which are effective in inhibiting indoleamine-N-methyl transferase and thus useful in the treatment of mental aberrations, such as schizophrenia. Also disclosed are processes for the preparation of such imidazoles; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions.
    Type: Grant
    Filed: July 7, 1975
    Date of Patent: October 19, 1976
    Assignee: Merck & Co., Inc.
    Inventor: Paul S. Anderson
  • Patent number: 3973017
    Abstract: Disclosed are 2,3,5,6-tetrahydro-8H-imidazo-[2,1-c][1,4]thiazines, analogues and derivatives thereof which are effective in inhibiting indoleamine-N-methyl transferase and thus useful in the treatment of mental aberrations, such as schizophrenia. Also disclosed are processes for the preparation of such imidazothiazines; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions.
    Type: Grant
    Filed: July 7, 1975
    Date of Patent: August 3, 1976
    Assignee: Merck & Co., Inc.
    Inventor: Paul S. Anderson